Immune responses to vaginal or systemic infection of BALB/c mice with herpes simplex virus type 2
- PMID: 72115
Immune responses to vaginal or systemic infection of BALB/c mice with herpes simplex virus type 2
Abstract
The temporal relationships among the humoral and cellular immune responses were defined in BALB/c mice after vaginal or systemic infection with herpes simplex virus type 2 (HSV-2). After vaginal infection, mice showed evidence of clinical vaginitis on days 4 to 6 and HSV-2 replication was detected locally in the vaginal secretions, cervix, vagina, and uterus before the virus subsequently spread to the central nervous system. Death from encephalitis occurred between 7 and 10 days after infection. Vaginal infection was associated with significant delayed type hypersensitivity and splenic proliferative cell-mediated immune responses which appeared during the acute infection and waned by 3 weeks. There was almost no evidence of a systemic neutralizing antibody response at any time after vaginal infection. In contrast to the local vaginal infection, systemic i.v. HSV-2 infection induced a humoral response as well as the two cellular immune responses. Although both cellular immune responses appeared during the acute infection (days 6 to 14) and persisted for approximately 5 weeks, the humoral response appeared in surviving animals and persisted for at least 4 months. Thus, vaginal HSV-2 infection was associated primarily with transient cellular immune responses, whereas i.v. HSV-2 infection induced prolonged systemic humoral and cellular immune responses.
Similar articles
-
Immune responses to vaginal or systemic infection of mice with herpes simplex virus type 2.IARC Sci Publ (1971). 1978;(24 Pt 2):759-63. IARC Sci Publ (1971). 1978. PMID: 221400
-
Viral isolation and systemic immune responses after intracameral inoculation of herpes simplex virus type 1 in Igh-1-disparate congenic murine strains.Invest Ophthalmol Vis Sci. 1990 Nov;31(11):2335-41. Invest Ophthalmol Vis Sci. 1990. PMID: 2173686
-
A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.Lab Invest. 1994 Mar;70(3):369-80. Lab Invest. 1994. PMID: 8145530
-
Cell-mediated immunity and immunosuppression in herpes simplex virus infection.Immunodeficiency. 1993;5(1):33-90. Immunodeficiency. 1993. PMID: 8167747 Review.
-
Cannabinoids and immunity to viruses.Adv Exp Med Biol. 1996;402:131-4. doi: 10.1007/978-1-4613-0407-4_18. Adv Exp Med Biol. 1996. PMID: 8787653 Review. No abstract available.
Cited by
-
Dendritic Cell Autophagy Contributes to Herpes Simplex Virus-Driven Stromal Keratitis and Immunopathology.mBio. 2015 Oct 27;6(6):e01426-15. doi: 10.1128/mBio.01426-15. mBio. 2015. PMID: 26507231 Free PMC article.
-
Effect of Environmental Enrichment on Aggression in BALB/cJ and BALB/cByJ Mice Monitored by Using an Automated System.J Am Assoc Lab Anim Sci. 2018 May 1;57(3):236-243. doi: 10.30802/AALAS-JAALAS-17-000122. Epub 2018 Apr 18. J Am Assoc Lab Anim Sci. 2018. PMID: 29669621 Free PMC article.
-
Autonomic nervous system involvement in experimental genital infection by herpes simplex virus type 2.Arch Virol. 1986;91(3-4):329-39. doi: 10.1007/BF01314291. Arch Virol. 1986. PMID: 3022683
-
Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus.Infect Immun. 1979 Mar;23(3):670-4. doi: 10.1128/iai.23.3.670-674.1979. Infect Immun. 1979. PMID: 313368 Free PMC article.
-
Effect of pyran on latency after herpes simplex virus infections.Antimicrob Agents Chemother. 1979 Apr;15(4):547-53. doi: 10.1128/AAC.15.4.547. Antimicrob Agents Chemother. 1979. PMID: 464586 Free PMC article.